Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-108,665
Closed -$197K 2886
2026
Q1
$197K Buy
108,665
+80,739
+289% +$140K ﹤0.01% 1755
2025
Q4
$37.7K Buy
+27,926
New +$39.8K ﹤0.01% 1899
2025
Q3
Sell
-55,620
Closed -$54K 2462
2025
Q2
$54K Buy
+55,620
New +$46.1K ﹤0.01% 1876
2023
Q3
Sell
-58,300
Closed -$31.7K 2138
2023
Q2
$31.7K Buy
+58,300
New +$37.4K ﹤0.01% 1856
2023
Q1
Sell
-98,800
Closed -$128K 2485
2022
Q4
$128K Sell
98,800
-282,990
-74% -$441K ﹤0.01% 2120
2022
Q3
$679K Buy
381,790
+342,968
+883% +$854K 0.01% 1537
2022
Q2
$88K Buy
38,822
+2,022
+5% +$4.84K ﹤0.01% 2166
2022
Q1
$121K Sell
36,800
-6,600
-15% -$23.2K ﹤0.01% 2177
2021
Q4
$198K Sell
43,400
-8,400
-16% -$63.4K ﹤0.01% 1739
2021
Q3
$372K Buy
51,800
+22,700
+78% +$167K ﹤0.01% 1416
2021
Q2
$234K Buy
+29,100
New +$246K ﹤0.01% 1598

Other funds holding OCGN

Steve Schonfeld's OCGN Position: Q2 2026 in Review

Steve Schonfeld sold out of Ocugen (OCGN) in Q2 2026, closing a stake of 108,665 shares — an estimated $197K sold.

Steve Schonfeld first reported a position in OCGN in Q2 2021 and held it in 11 quarters. The position peaked at $679K in Q3 2022. 146 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Steve Schonfeld reported no remaining Ocugen position as of Q2 2026 after selling out during the quarter.
  • Steve Schonfeld sold 108,665 Ocugen shares in Q2 2026, an estimated $197K.
  • Steve Schonfeld first reported a position in Ocugen in Q2 2021 and held it in 11 quarters.
  • Steve Schonfeld's Ocugen position peaked at $679K in Q3 2022.
  • 146 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.